Hypertension

November 14, 2022

Estimating the Time Needed to Potentially Derive Clinical Benefit from Intensive BP Treatment in Patients 60 Years and Older

A secondary analysis of 27,414 patients from six trials was done to estimate the time needed to potentially derive clinical benefit from intensive BP treatment in hypertensive patients 60 years and older.

The Study Found that IBPT with 100 patients ≥60 Years of Age with Hypertension for Approximately 3 Years Would Prevent 1 MACE.

BP: Blood Pressure; MACE: Major Adverse Cardiovascular Events; IBPT: Intensive Blood Pressure Treatment;
HR: Hazard Ratio

References:

Chen, T., Shao, F., Chen, K., Wang, Y., Wu, Z., Wang, Y., Gao, Y., Cornelius, V., Li, C. and Jiang, Z., 2022. Time to
Clinical Benefit of Intensive Blood Pressure Lowering in Patients 60 Years and Older With Hypertension. JAMA
Internal Medicine, 182(6), p.660.

603

Lifestyle Interventions Reduce Need for Guideline-Directed Antihypertensive Medication

Suppression of Excessive Seasonal Blood Pressure Changes Contributes to Prevention of Cardiovascular Disease

Chlorthalidone Monotherapy Has Higher Failure Rates Than Amlodipine Monotherapy

Acute Moderate-Intensity Exercise can Reduce Resting Blood Pressure in Young Hypertensive Men

What are the Factors Associated with Hypertension Control Among Treated Middle-Aged Adults?

Does Beverage Intake During Childhood Determine Risk of Hypertension and Hyperlipidemia During Adulthood?

Understanding the Burden of Undiagnosed Hypertension and its Associated Factors Among the Adult Population

Is Hypertension Associated with Lower Antibody Titres and Breakthrough Infection Following COVID-19 Vaccination?

Cookie Consent

Hypertension

Estimating the Time Needed to Potentially Derive Clinical Benefit from Intensive BP Treatment in Patients 60 Years and Older

Lifestyle Interventions Reduce Need for Guideline-Directed Antihypertensive Medication

Suppression of Excessive Seasonal Blood Pressure Changes Contributes to Prevention of Cardiovascular Disease

Chlorthalidone Monotherapy Has Higher Failure Rates Than Amlodipine Monotherapy

Acute Moderate-Intensity Exercise can Reduce Resting Blood Pressure in Young Hypertensive Men

What are the Factors Associated with Hypertension Control Among Treated Middle-Aged Adults?

Does Beverage Intake During Childhood Determine Risk of Hypertension and Hyperlipidemia During Adulthood?

Understanding the Burden of Undiagnosed Hypertension and its Associated Factors Among the Adult Population

Is Hypertension Associated with Lower Antibody Titres and Breakthrough Infection Following COVID-19 Vaccination?

The Prevalence and Levels of Awareness of Hypertension Among Young Adults

Is COVID-19-Related Anxiety Associated With Greater Risk of CVD Events?

Indian Clinicians’ Perspectives on Hypertension in Young Adults

Finding the Link Between Food Intake Time and Long-Term Survival Among Patients with Diabetes

Is a FDC of Metoprolol, Telmisartan & Chlorthalidone Efficacious & Safe in the Treatment of Essential HTN?

Do Hypertension and Hyperlipidemia Synergistically Increase the Risk of Ischemic Stroke?

The REAL YOUNG Hypertension Study

Can Fish Oil Supplements Help Reduce the Risk of Cardiovascular Events?

Prevalence of NSAID Use in Patients with Hypertensive Crisis (HTN-C)

Does Aspirin Use Increase The Risk Of Heart Failure?

Can HIIT Workouts Improve Arterial Stiffness?

Sacubitril–Valsartan Useful In Treating Apparent Resistant Hypertension

Intensive Blood-Pressure Control in Older Patients Lowers Cardiovascular Events

Body-Weight Resistance Exercise Can Reduce BP In Middle-Aged Adults With Hypertension

Aerobic and Resistance Exercises can Lower Blood Pressure in Older Hypertensive Women

Improved Sleep efficiency Found to Reduce Blood Pressure

Vitamin D3 Supplementation in Hypertensive Patients Does Not Lower Systemic Inflammation Markers

Resources